DCP.JO JNB
Dis-Chem Pharmacies Limited
1W: +2.6%
1M: -0.8%
3M: -16.6%
YTD: -25.4%
1Y: -20.0%
3Y: +14.7%
5Y: -4.8%
R2,723.00 ($1.64)
+15.00 (+0.55%)
Weekly Expected Move ±2.9%
R2564
R2643
R2721
R2799
R2878
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$905M
-52.1% ▼
5Y CAGR: -6.4%
Capital Expenditures
$1.4B
-36.5% ▼
5Y CAGR: +31.0%
Free Cash Flow
-$497M
-157.6% ▼
Dividends Paid
$472M
-11.2% ▼
Buybacks
$33M
+50.2% ▲
Net Change in Cash
-$766M
-495.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $941M | $1.2B | $1.4B | $984M | $1.6B |
| Depreciation & Amort. | $705M | $855M | $1.0B | $1.1B | $1.1B |
| Stock-Based Comp. | $6M | $19M | $21M | $24M | $29M |
| Change in Working Capital | -$335M | $45M | -$718M | -$175M | -$924M |
| Other Non-Cash Items | $376M | $293M | $283M | -$5M | -$979M |
| Operating Cash Flow | $1.1B | $1.4B | $854M | $1.9B | $905M |
| — Investing Activities — | |||||
| Capital Expenditures | -$401M | -$377M | -$1.1B | -$1.0B | -$1.4B |
| Acquisitions (Net) | -$391M | -$427M | -$24M | -$36M | -$128M |
| Investment Purchases | -$4M | -$162M | -$21M | $0 | $0 |
| Investment Sales | $4M | $2M | $21M | $0 | $0 |
| Other Investing | $12M | $169M | $23M | $435K | $33M |
| Investing Cash Flow | -$780M | -$796M | -$1.1B | -$1.1B | -$1.5B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$66M | $105M | $391M | $459M | $488M |
| Stock Repurchased | $0 | -$12M | -$29M | -$65M | -$33M |
| Dividends Paid | -$40M | -$459M | -$466M | -$424M | -$472M |
| Other Financing | -$432M | -$537M | -$565M | -$601M | -$158M |
| Financing Cash Flow | -$498M | -$445M | -$203M | -$632M | -$175M |
| Net Change in Cash | -$164M | $145M | -$441M | $193M | -$766M |
| Cash End of Period | $136M | $281M | -$160M | $33M | -$732M |
| Free Cash Flow | $723M | $1.0B | -$236M | $863M | -$497M |